Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Hematology
  •  Gastrointestinal Cancer
  •  Paediatric Cancers
  •  Thoracic Oncology
  •  Surgical Oncology
  •  Immunology
  •  Head and Neck Oncology
  •  Prostate Cancer

Abstract

Citation: Clin Oncol. 2023;8(1):2001.DOI: 10.25107/2474-1663.2001

Advances in Positron Emission Tomography for Proton Therapy Dose Monitoring

Rameshwar Prasad and Jagadeesh S Singh

Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Centre, USA

*Correspondance to: Rameshwar Prasad 

 PDF  Full Text Research Article | Open Access

Abstract:

Proton therapy is increasingly becoming a popular radiation therapy modality owing to its unique characteristics of Bragg peak. Proton therapy suffers from various uncertainties introduced during radiation treatment planning and dose delivery. PET imaging of proton induced positron emitter distributions provides in-vivo monitoring and verification of dose delivered in proton therapy. In
this review physics principles, history, development, and applications of PET to monitor and verify radiation dose delivered in proton therapy are presented. Different configurations of in-room inbeam, in-room off-beam, and off-room PET with proton beam are discussed. Insights on future developments and applications of PET as proton dose monitoring and verifying are presented.

Keywords:

Proton therapy; Positron emission tomography; Range; Dosimetry; Detector

Cite the Article:

Prasad R, Singh JS. Advances in Positron Emission Tomography for Proton Therapy Dose Monitoring. Clin Oncol. 2023;8:2001..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

High CDX2 Expression Predicts a Favorable Prognosis in Patients with Early-Stage Gastric Adenocarcinoma
 Abstract  PDF  Full Text
Ezrin Intracellular Cytoskeleton Marker is Over Expressed in Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
 Abstract  PDF  Full Text
View More...